Decreased fertility in female mice lacking urokinase plasminogen activator

Reprod Biol. 2024 Mar;24(1):100840. doi: 10.1016/j.repbio.2023.100840. Epub 2023 Dec 19.

Abstract

It is well established that mouse ovarian granulosa cells secrete urokinase plasminogen activator (uPA) under gonadotropin stimulation. The synthesis and secretion of the enzyme correlate well with the time of follicular rupture in vivo. Moreover, uPA is secreted by the trophoblast at the time of implantation. In the present study, we have analyzed whether the absence of uPA could influence follicular growth, ovulation, and embryo implantation. Our data show fewer preantral follicles in uPA-/- ovaries but no decrease in hormonally induced ovulation. However, we observed a significant decrease in the number of implanted embryos in uPA-/- animals and, therefore, a lower number of pups per family. Adding uPA to the epithelial and stromal uterine cell culture medium strongly upregulates the expression of prostaglandin-endoperoxide synthase 2 (Ptgs2), the enzyme required for prostaglandin production and embryo implantation. The uPA inhibitor amiloride abrogated this increase.

Keywords: Embryos; Implantation; Ovarian follicles; Prostaglandin-endoperoxide synthase 2; Urokinase plasminogen activator; Uterine epithelial cells.

MeSH terms

  • Animals
  • Female
  • Fertility
  • Gonadotropins* / pharmacology
  • Mice
  • Ovulation
  • Urokinase-Type Plasminogen Activator* / genetics
  • Urokinase-Type Plasminogen Activator* / metabolism

Substances

  • Urokinase-Type Plasminogen Activator
  • Gonadotropins